Clinical Trials Sponsored by PHARMACIA SAS

Total 11837 results

Institut Claudius Regaud
PHARMACIA SAS

Completed

Exemestane (Aromasine) + Tamoxifen - Breast Neo-Adjuvant (TAMARO)

Breast Neoplasms

France
Sankom SA
InterMedService SA; Pharmaxi LLC

Unknown

Study to Evaluate Impact SANKOM Patent Socks in Patients With CVI

Chronic Venous Insufficiency

Ukraine
University of Lausanne
Pharmacia

Completed

Nicotine Substitute Prescribed at Hourly Intake or ad Libitum for Heavy Smokers Willing to Quit (SUNIC)

Smoking Cessation

Switzerland
Pharmaxis

Recruiting

Effect of PXS-4728A on Microglia Activation in Participants With Isolated Rapid Eye Movement Sleep Behaviour Disorder

REM Sleep Behavior Disorder

Australia, United Kingdom
Pharmaxis

Withdrawn

A Pilot Safety Study of Inhaled Dry Powder Mannitol in Acute Exacerbations of COPD

COPD | Exacerbation

Australia
Pharmaxis

Completed

Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis

Bronchiectasis

United States, United Kingdom, Australia, New Zealand, Argentina, Belgium, Chile, Germany, Netherlands
Pharmaxis

Completed

Crossover Trial Determining the Efficacy of Dry Powder Mannitol to Improve Lung Function in Subjects Aged 6-17 Years

Cystic Fibrosis

United Kingdom
Pharmaxis

Completed

Efficacy of TPI ASM8 During a 14-Day Allergen Challenge

Asthma

Canada
Pharmaxis

Terminated

Safety and Efficacy of Two Dosages of Inhaled TPI ASM8 Compared to Placebo in Mild to Moderate Asthmatic Patients

Asthma

Canada
Pharmaxis

Completed

Multiple Dose ASM8 in Mild Asthmatics

Asthma

Canada
Pharmaxis

Completed

A Pilot Study to Investigate Administration of Mannitol Via a Novel Dry Powder Inhaler Device

Healthy | Bronchiectasis

Australia
Pharmaxis

Completed

Cystic Fibrosis (CF) Flow Rates Study

Cystic Fibrosis
Pharmaxis

Completed

Inspiratory Flow and Volumes in Bronchiectatics

Bronchiectasis

Australia
Hannover Medical School
Pharmacia

Completed

L-Arginine and Erectile Dysfunction

Erectile Dysfunction

Germany
Pharmaxis

Completed

A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects

Cystic Fibrosis

United States, Spain, Israel, Belgium, Czechia, South Africa, Italy, Mexico, Argentina, Australia, Canada, Hungary, New Zealand, Poland, Romania, Russian Federation, Slovakia, Ukraine
Pharmaxis

Completed

A Two-part Pharmacokinetic Study of PXS-5382A in Healthy Adult Males

Pharmacokinetics

Australia
Pharmaxis

Completed

Aridol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPD

Lung Diseases, Obstructive

Australia
Pharmaxis

Completed

Efficacy and Safety of Four Escalating Dose Regimens of TPI ASM8 in Patients With Allergic Asthma

Asthma

Canada
Pharmaxis

Withdrawn

Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Inhaled TPI 1100 in Healthy Volunteers

Chronic Obstructive Pulmonary Disease
Pharmaxis

Withdrawn

A Single Blind Study to Evaluate the Safety, Tolerability and Explore the Efficacy of 8.0 mg ASM8 Inhaled Daily for 14 Days in Severe Asthma

Asthma
Pharmaxis

Completed

Long Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis - A Safety and Efficacy Study

Cystic Fibrosis

Ireland, United Kingdom, Australia
Pharmaxis

Completed

High Dose Inhaled Mannitol Study

Bronchiectasis

Australia
Pharmaxis

Completed

Pharmacokinetics of Inhaled Mannitol in Cystic Fibrosis Patients (DPM-PK-102)

Cystic Fibrosis

Australia, United Kingdom
Pharmaxis

Completed

Mannitol Dose Response Study in Cystic Fibrosis

Cystic Fibrosis

Canada, Argentina
Apokus AS
Norwegian Pharmacy Association

Recruiting

Effects of Medisinstart for Type 2 Diabetes

Type 2 Diabetes

Norway
Apokus AS
Norwegian Pharmacy Association

Completed

Effectiveness of "Medisinstart"

Cardiovascular Diseases

Norway
Hannover Medical School
Pharmacia

Completed

Effects of Growth Hormone on the Nitric Oxide Pathway

Cardiovascular Disease

Germany
Pharmaxis

Completed

Inhaled TPI-1020 Versus Inhaled Budesonide in Smokers With Mild Reversible Asthma

Asthma

Canada
Pharmaxis

Completed

Safety, Tolerability and PD Activity of Inhaled TPI 1020 Versus Inhaled Budesonide in COPD Patients

Copd Bronchitis

Canada
Pharmaxis

Completed

A Phase 2 Study to Determine the Safety and Efficacy of Inhaled Dry Powder Mannitol in Cystic Fibrosis

Cystic Fibrosis

Australia, New Zealand
Pharmaxis

Completed

Comparison of Inhaled Mannitol and rhDNase in Children With Cystic Fibrosis

Cystic Fibrosis

United Kingdom
Pharmaxis

Completed

Ability of Aridol to Detect Bronchial Hyperresponsiveness in Suspected Asthmatics

Asthma

United States
Pharmaxis

Completed

Safety and Efficacy of Bronchitol in Bronchiectasis

Bronchiectasis

Australia, New Zealand, United Kingdom
Pharmaxis

Completed

Inspiratory Flow Using the Osmohaler

Asthma
Pharmaxis

Completed

A Pharmacokinetic and Bioavailability Study of Mannitol for Inhalation Using Normal Subjects

Healthy Volunteers
PharmaIN

Recruiting

Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics

Cirrhosis, Liver | Liver Fibrosis | Ascites Hepatic

United States
Jonsson Comprehensive Cancer Center
Pharmacia

Completed

Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer

Lung Cancer

United States
M.D. Anderson Cancer Center
Pharmacia

Completed

Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract

Carcinoma, Neuroendocrine | Gastrointestinal Cancer

United States
VascuScript Pharmacy
Community Pharmacy Foundation

Completed

Minimizing Risk and Maximizing Outcomes in Geriatric Patients Through Integrated Clinical Pharmacy Services in an Innovative Model of Community Practice

Medication Adherence | Health Literacy | Geriatric Patient Care Improvement | Pharmacy Economic Improvement

United States
PharmaBio Corporation

Recruiting

Clinical Study of PAL-222 Targeting Patients With Myopic Chorioretinal Atrophy (PAMyCA)

Myopic Chorioretinal Atrophy

Japan
Mission Pharmacal

Terminated

Efficacy and Safety of Using MPC-5971 in Subjects Undergoing Shock Wave Lithotripsy

Nephrolithiasis

United States
PharmAkea, Inc.

Completed

Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of PAT-1251 in Healthy Adult Subjects

Healthy

United Kingdom
Mission Pharmacal

Unknown

Phase II Proof of Concept Study in Uncomplicated UTI

Urinary Tract Infections

United States
Mission Pharmacal

Completed

Treatment of Bacterial Vaginosis With Oral Tinidazole

Bacterial Vaginosis

United States
M.D. Anderson Cancer Center
Pharmacia; LifeCell

Completed

rhTPO Mobilized Auto Cryo Platelets For GYN Patients Receiving Carboplatin

Neoplasms, Gynecologic

United States
GeNeuro Innovation SAS

Completed

Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis Disease (LOMBARD)

Multiple Sclerosis (MS) | Clinically Isolated Syndrome (CIS) | Secondary Progressive MS | Primary Progressive MS | Relapsing-Remitting MS

France, Spain, Switzerland
GeNeuro Innovation SAS

Completed

Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Normal Population (CONTROL)

Multiple Sclerosis

France
GeNeuro Innovation SAS

Completed

First-in-Human Study With GNbAC1 in Healthy Volunteers

Multiple Sclerosis
GeNeuro Innovation SAS

Completed

Safety Study of GNbAC1 Monoclonal Antibody in Healthy Male Volunteers

Healthy Volunteers

Germany
GeNeuro Innovation SAS

Completed

Clinical Trial Assessing Temelimab Following Rituximab Treatment in Patients With Relapsing Forms of Multiple Sclerosis (ProTEct-MS)

Multiple Sclerosis

Sweden

3

Subscribe